Skip to main content
. 2023 Mar 29;46(6):698–706. doi: 10.1002/clc.24014

Figure 4.

Figure 4

Association between time and the estimated changes in the (A) MDA‐LDL level, (B) LDL‐C level, and (C) MDA‐LDL/LDL‐C ratio according to the dose of febuxostat. LDL‐C, low‐density lipoprotein cholesterol; MDA‐LDL, malondialdehyde‐modified low‐density lipoprotein.